DSpace university logo mark
Advanced Search
Japanese | English 

NAOSITE : Nagasaki University's Academic Output SITE > School of Medicine > Bulletin > Acta Medica Nagasakiensia > Volume 34, No. 2-4 >

Expression of EGF and, Ras and Myc Oncogene Products in Normal, Graves' Thyroid, Adenoma, and Carcinoma of the Thyroid


File Description SizeFormat
acta34_02_12_t.pdf1.23 MBAdobe PDFView/Open

Title: Expression of EGF and, Ras and Myc Oncogene Products in Normal, Graves' Thyroid, Adenoma, and Carcinoma of the Thyroid
Authors: Toda, Takayoshi / Deguchi, Shigeru / Kurihara, Kohtaro / Hamada, Yuhshi / Muto, Yoshihiro / Kitsukawa, Keizo
Issue Date: 9-Dec-1989
Citation: Acta medica Nagasakiensia. 1989, 34(2-4), p.70-75
Abstract: An immunohistochemical study of EGF, and products of ras and myc oncogenes was carried out in 47 cases of non-neoplastic and neoplastic lesions of the thyroid. Normal thyroid tissues showed no significant immunostaining reaction to antibodies for EGF, and products of ras and myc oncogenes. The incidence of EGF positivity was 27%, 46% and 76% in Graves' disease, follicular adenoma, and carcinoma, repectively. The incidence of positivity of ras oncogene product was 27%, 38%, and 82% in Graves' disease, follicular adenoma and carcinoma, respectively. The incidence of positivity of myc oncogene product was 18%, 46% and 71% in Graves' disease, Follicular adenoma, and carcinoma, respectively. These results suggest that EGF, and ras and myc oncogenes or proto-oncogenes play a role in neoplastic lesions of the thyroid.
URI: http://hdl.handle.net/10069/15764
ISSN: 00016055
Type: Departmental Bulletin Paper
Text Version: publisher
Appears in Collections:Volume 34, No. 2-4

Citable URI : http://hdl.handle.net/10069/15764

All items in NAOSITE are protected by copyright, with all rights reserved.

 

Valid XHTML 1.0! Copyright © 2006-2015 Nagasaki University Library - Feedback Powerd by DSpace